Wednesday, 22.09.2010

08:30 - 10:30	470	Acquired weakness in the intensive care unit: "the long and winding road" to regain a normal life	Symposium
08:30 - 10:30	471	Phenotypic fingerprinting in asthma and COPD: systems biology is entering the clinic	Symposium
08:30 - 10:30	472	New advances in the use of lasers for treatment	Hot topics
08:30 - 10:30	473	ERS Guidelines for the diagnosis and management of lymphangioleiomyomatosis	Symposium
08:30 - 10:30	474	Treatment of bronchial infection: beyond the exacerbations	Symposium
08:30 - 10:30	475	Pathology and immunology of COPD	Oral Presentation
08:30 - 10:30	476	Biomarkers and diagnosis of allergic inflammatory diseases	Oral Presentation
08:30 - 10:30	477	Risk factors for asthma in children and adults including severe disease	Oral Presentation
08:30 - 10:30	478	Childhood pneumonia: from prevention to complications	Oral Presentation
08:30 - 10:30	479	Sleep apnoea: insights from basic and clinical research	Oral Presentation
08:30 - 10:30	480	Waves and needles: ultrasound guided diagnostic	Oral Presentation
08:30 - 10:30	481	Paediatric asthma treatment and monitoring	Oral Presentation
08:30 - 10:30	482	Tuberculosis control	Oral Presentation
08:30 - 10:30	483	Exercise in COPD	E-Communication Session
08:30 - 10:30	484	Respiratory system involvement in non-pulmonary disorders	E-Communication Session
08:30 - 10:30	485	Staging of lung cancer	E-Communication Session
08:30 - 10:30	486	Comorbidities and disease management in primary care	E-Communication Session
08:30 - 10:30	487	Aspects of severe asthma	E-Communication Session
08:30 - 10:30	488	Induced sputum in relation: a fresh look on phenotyping and monitoring	E-Communication Session
10:45 - 12:45	489	Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma	Symposium
10:45 - 12:45	490	Global health: epidemiology of respiratory diseases in Latin America and their impact in Europe (joint symposium ERS-SEPAR-ALAT)	Symposium
10:45 - 12:45	491	Severe asthma: reviewing the last decade and looking to the next. A report of the ERS/ATS Task Force	Symposium
10:45 - 12:45	492	The lung cancer patient in the intensive care unit	Symposium
10:45 - 12:45	493	Airway smooth muscle cells: multifunctional cells in asthma pathogenesis	Symposium
10:45 - 12:45	494	Clinical management of venous thrombosis, pulmonary embolism and thrombophilia	Oral Presentation
10:45 - 12:45	495	New mechanisms in chronic lung diseases	Oral Presentation
10:45 - 12:45	496	COPD: symptoms and staging	Oral Presentation
10:45 - 12:45	497	Bronchodilators in airways disease	Oral Presentation
10:45 - 12:45	498	Functional assessment of paediatric lung disease	Oral Presentation
10:45 - 12:45	499	Monitoring chronic respiratory diseases in Europe: what we know, new challenges and new opportunities	Hot topics
10:45 - 12:45	500	New aspects of treatment of lower respiratory tract infections	Oral Presentation
10:45 - 12:45	501	Indoor exposures to irritant chemicals, allergens and moulds and respiratory health of children and adults	Oral Presentation
10:45 - 12:45	502	Pulmonary circulation: clinical aspects	E-Communication Session
10:45 - 12:45	503	Tuberculosis epidemiology	E-Communication Session
10:45 - 12:45	504	Paediatric asthma, rhinitis and management	E-Communication Session
10:45 - 12:45	505	Animal models of asthma and lung inflammation	E-Communication Session
10:45 - 12:45	506	Biomarkers in diffuse parenchymal lung disease	E-Communication Session
10:45 - 12:45	507	Novel cellular mechanisms in lung disease	E-Communication Session